Beauty firms test ‘Ozempic face’ treatments as weight-loss drug market booms
- Beauty firms are chasing the “Ozempic face” market, with Galderma, Natura and L’Oreal testing treatments.
- Experts say the sagging comes from rapid weight loss itself, not the drugs, calling the term misleading.
- Pfizer estimates obesity drug sales could hit $150 billion a year by 2030, with related treatments at $2 billion.
- Experts say fillers work better than creams, which cannot reach the fat layer where facial volume is lost.
Source: economictimes.indiatimes.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
